Relief Therapeutics Holding SA (RLFTF)
OTCMKTS · Delayed Price · Currency is USD
3.600
+0.010 (0.27%)
Oct 24, 2025, 2:48 PM EDT
RLFTF Market Cap
RLFTF has a market cap or net worth of $44.63 million as of October 24, 2025. Its market cap has decreased by -26.08% in one year.
Market Cap
44.63M
Enterprise Value
31.30M
Revenue
5.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
$3.60
Market Cap Chart
Since July 19, 2016, RLFTF's market cap has decreased from 93.95M to 44.63M, a decrease of -52.50%. That is a compound annual growth rate of -7.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 44.63M | -23.32% |
| Dec 30, 2024 | 58.21M | 96.41% |
| Dec 29, 2023 | 29.64M | -79.23% |
| Dec 30, 2022 | 142.71M | -52.45% |
| Dec 30, 2021 | 300.10M | -69.64% |
| Dec 30, 2020 | 988.40M | 45,169.87% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 670.91M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 344.81M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.16M |
| American Oncology Network | 291.52M |